PEG-coated Gold Nanoparticles Attenuate Β-Adrenergic Receptor-Mediated Cardiac Hypertrophy

Yuhui Qiao,Baoling Zhu,Aiju Tian,Zijian Li
DOI: https://doi.org/10.2147/ijn.s130951
IF: 7.033
2017-01-01
International Journal of Nanomedicine
Abstract:Gold nanoparticles (AuNPs) are widely used as a drug delivery vehicle, which can accumulate in the heart through blood circulation. Therefore, it is very important to understand the effect of AuNPs on the heart, especially under pathological conditions. In this study, we found that PEG-coated AuNPs attenuate β-adrenergic receptor (β-AR)-mediated acute cardiac hypertrophy and inflammation. However, both isoproterenol, a non-selective β-AR agonist, and AuNPs did not induce cardiac function change or cardiac fibrosis. AuNPs exerted an anti-cardiac hypertrophy effect by decreasing β1-AR expression and its downstream ERK1/2 hypertrophic pathway. Our results indicated that AuNPs might be safe and have the potential to be used as multi-functional materials (drug carrier systems and anti-cardiac hypertrophy agents).
What problem does this paper attempt to address?